HARP

Harpoon Therapeutics, Inc. Common Stock

Delisted

HARP was delisted on the 8th of March, 2024.

84 hedge funds and large institutions have $196M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$463K
Puts
$457K
Net Calls
Net Calls Change

Top Buyers

1 +$14.6M
2 +$4.91M
3 +$2.42M
4
O
OrbiMed
New York
+$2.21M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.81M

Top Sellers

1 -$9.41M
2 -$3.78M
3 -$2.64M
4
LCM
Laurion Capital Management
New York
-$2.42M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.18M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$840K
27
$794K
28
$768K
29
$676K
30
$642K
31
$519K
32
$510K
33
$419K
34
$390K
35
$377K
36
$369K
37
$315K
38
$281K
39
$266K
40
$223K
41
$193K
42
$179K
43
$178K
44
$175K
45
$152K
46
$147K
47
$133K
48
$113K
49
$112K
50
$108K